Logo-jre
Submitted: 29 Aug 2022
Accepted: 01 Oct 2022
ePublished: 22 Oct 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Endocrinol. 2022;8: e19065.
doi: 10.34172/jre.2022.19065
  Abstract View: 73
  PDF Download: 44

Hypothesis

Colchicine; An inflammasome inhibitor and a potential therapy in severe COVID19?

Sara Bahadoram 1 ORCID logo, Mohammad-Reza Mahmoudian-Sani 1 ORCID logo, Bijan Keikhaei 1 ORCID logo, Mohammad Bahadoram 1* ORCID logo, Amar Helalinasab 2 ORCID logo, Esma'il Akade 3 ORCID logo

1 Thalassemia and Hemoglobinopathy Research Center, Research Institute of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2 Silk Clinics, Dubai Health Care City Dubai, United Arab Emirates.
3 Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
*Corresponding Author: Corresponding Author: Mohammad Bahadoram, Email: , Email: mohammadbahadoram@yahoo.com

Citation: Bahadoram S, Mahmoudian-Sani MR, Keikhaei B, Bahadoram M, Helalinasab A, Akade E. Colchicine; An inflammasome inhibitor and a potential therapy in severe COVID19? J Ren Endocrinol. 2022;8:e19065. doi: 10.34172/jre.2022.19065.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 74

Your browser does not support the canvas element.


PDF Download: 44

Your browser does not support the canvas element.